BILL WOULD EMPOWER FDA ON DRUG SAFETY

被引：0

|

作者：

不详

机构：

来源：

CHEMICAL & ENGINEERING NEWS | 2010年 / 88卷 / 32期

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：22 / 22

页数：1

相关论文

共 50 条

[41] US FDA reports new steps in drug safety
[J]. Reactions Weekly, 2007, 1138 (1) : 3 - 3
[42] Bill Would Require Law-Breaking Drug Companies to Help Fund Research
Rubin, Rita
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (10): : 1004 - 1004
[43] US FDA 2009 drug safety warnings analysed
[J]. Reactions Weekly, 2012, 1388 (1) : 4 - 4
[44] FDA under pressure of address drug safety issues
Wechsler, J
[J]. BIOPHARM INTERNATIONAL, 2005, 18 (02) : 16 - 17
[45] FDA Sets Policies to Enhance Drug Security and Safety
Wechsler, Jill
[J]. BIOPHARM INTERNATIONAL, 2015, 28 (02) : 10 - 11
[46] A Difficult Balance - Pain Management, Drug Safety, and the FDA
Woodcock, Janet
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (22): : 2105 - 2107
[47] US FDA Enhancing Postmarketing Drug Safety Surveillance
不详
[J]. PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 64 - 64
[48] FDA planning automated system for better drug safety
Lane, Kenneth W.
[J]. TELEMEDICINE JOURNAL AND E-HEALTH, 2006, 12 (06): : 611 - 612
[49] Report on Drug Safety and the US FDA by the Institute of Medicine
Anthony W. Fox
[J]. International Journal of Pharmaceutical Medicine, 2006, 20 (5) : 289 - 291
[50] US FDA enhancing postmarketing drug safety surveillance
[J]. Reactions Weekly, 2019, 1780 (1) : 3 - 3

← 1 2 3 4 5 →